MoneyWorks4Me

The company witnessed a 16.70% growth in the revenue at Rs. 825.60 millions for the quarter ended March 2023 as compared to Rs. 707.48 millions during the year-ago period.A slim rise of 21.91% was recorded in the Net profit for the quarter ended March 2023 to Rs. 174.97  millions  From Rs. 143.52 millions.The company reported a good operating profit of 260.92 millions compared to 205.52 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 825.60 707.48 16.70 3115.29 2727.98 14.20 3115.29 2727.98 14.20
Other Income 28.10 51.69 -45.64 98.08 90.80 8.02 98.08 90.80 8.02
PBIDT 260.92 205.52 26.96 846.96 817.28 3.63 846.96 817.28 3.63
Interest 0.57 0.52 9.62 1.35 0.95 42.11 1.35 0.95 42.11
PBDT 260.35 205.00 27.00 845.61 816.33 3.59 845.61 816.33 3.59
Depreciation 27.57 25.34 8.80 102.83 95.61 7.55 102.83 95.61 7.55
PBT 232.78 179.66 29.57 742.78 720.72 3.06 742.78 720.72 3.06
TAX 57.81 36.14 59.96 187.51 175.61 6.78 187.51 175.61 6.78
Deferred Tax 5.52 -3.52 -256.82 4.97 -4.56 -208.99 4.97 -4.56 -208.99
PAT 174.97 143.52 21.91 555.27 545.11 1.86 555.27 545.11 1.86
Equity 223.65 223.60 0.02 223.65 223.60 0.02 223.65 223.60 0.02
PBIDTM(%) 31.60 29.05 8.79 27.19 29.96 -9.25 27.19 29.96 -9.25

Advanced Enzyme Tech Share Price

306.90 3.65 (1.20%)
19-Aug-2026 14:09 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1893.00
Dr. Reddys Labs. 1169.80
Cipla 1418.20
Lupin 2221.50
Zydus Lifesciences 1107.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: